{"id":107342,"date":"2026-11-13T20:33:57","date_gmt":"2026-11-13T19:33:57","guid":{"rendered":"https:\/\/www.veeva.com\/eu\/?p=107342"},"modified":"2026-11-13T23:06:21","modified_gmt":"2026-11-13T22:06:21","slug":"powering-faster-multi-agency-data-exchange","status":"publish","type":"post","link":"https:\/\/pantheon.veeva.com\/eu\/blog\/powering-faster-multi-agency-data-exchange\/","title":{"rendered":"Powering Faster Multi-Agency Data Exchange"},"content":{"rendered":"

Global regulatory reliance speeds product approvals by eliminating the redundant, multi-year evaluation cycles that traditionally occur as a product moves through different jurisdictions. The World Health Organization<\/a> (WHO) defines reliance as “the act whereby the national regulatory authority (NRA) in one jurisdiction may take into account and give significant weight to assessments performed by another national regulatory authority or trusted institution, or to any other authoritative information in reaching its own decision.” Critically, this is not a delegation of authority; the relying NRA remains “independent, responsible, and accountable regarding the decisions taken, even when it relies on the decisions and information of others.”<\/p>\n

The four paths to regulatory approval<\/h2>\n

Identifying the appropriate reliance pathway and requirements is the first step in a global submission strategy. Understanding the various reliance models helps regulatory leaders anticipate efficiency gains and determine which reliance options are required vs. optional. While Veeva RIM<\/a> supports all reliance pathways, some are administrative by nature while others benefit from shared submission platforms.<\/p>\n